Leishmania infantum AS A CAUSATIVE AGENT OF CUTANEOUS LEISHMANIASIS IN THE STATE OF MATO GROSSO DO SUL, BRAZIL by CASTRO, Ludiele Souza et al.
(1) Universidade Federal de Mato Grosso do Sul, Programa de Pós-Graduação em Doenças Infecciosas e Parasitárias, Cidade Universitária s/n, 79090-900 Campo Grande, MS, Brazil.
(2) Fundação Oswaldo Cruz /Fiocruz Mato Grosso do Sul, Rua Gabriel Abrão 92, 79081-746 Campo Grande, MS, Brazil.
(3) Universidade Federal de Mato Grosso do Sul, Ambulatório de Dermatologia, Hospital Universitário, Cidade Universitária s/n, 79090-900 Campo Grande, MS, Brazil.
(4) Fundação Oswaldo Cruz, Laboratório de Leishmanioses, Centro de Pesquisas René Rachou, Av. Augusto de Lima 1715 Bairro Preto, 30190-002 Belo Horizonte, MG, Brazil.
(5) Universidade Federal de Mato Grosso do Sul, Laboratório de Parasitologia Clínica (LAC), Cidade Universitária s/n, 79090-900 Campo Grande, MS, Brazil.
Correspondence to: Maria Elizabeth Moraes C. Dorval. E-mail: mecdorval@gmail.com




Leishmania infantum AS A CAUSATIVE AGENT OF CUTANEOUS LEISHMANIASIS  
IN THE STATE OF MATO GROSSO DO SUL, BRAZIL
Ludiele Souza CASTRO(1), Adriana de Oliveira FRANÇA(1), Eduardo de Castro FERREIRA(2), Günther HANS FILHO(3), Minoru German HIGA JÚNIOR (1),  
Célia Maria Ferreira GONTIJO(4), Agnes Antônia Sampaio PEREIRA(4) & Maria Elizabeth Moraes C. DORVAL(5)
SUMMARY
Cutaneous leishmaniasis is caused by different species of the Leishmania genus. Leishmania (Leishmania) infantum, causing 
cutaneous leishmaniasis, has been described in patients living in areas where visceral leishmaniasis is endemic. In this study, it was 
possible to characterize this species in seven slides from cutaneous tissue imprints from patients with cutaneous leishmaniasis in the 
State of Mato Grosso do Sul, Brazil.
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The present study reports a case of Leishmania (Leishmania) 
infantum as an agent of cutaneous leishmaniasis (CL) in patients from 
the State of Mato Grosso do Sul (Brazil). This is the first description of 
CL in immunocompetent patients in Brazil.
The species L. infantum was first associated with CL in France, in 
19801, where more autochtonous cases have been reported since then1,2,3. 
Since this first retrieval, several cases of CL have been reported in other 
Mediterranean countries4,5,6,7,8. Cutaneous leishmaniasis cases due to 
L. infantum are mainly reported in areas where the visceral disease is 
endemic.
In Mato Grosso do Sul (Fig. 1), leishmaniasis is endemic and is a 
significant threat to public health9,10, where 42.9 cases were reported 
per 100,000 inhabitants from 2010 to 2013 for visceral leishmaniasis 
(VL), and 21.6 cases per 100,000 inhabitantsfor CL in the same period. 
Despite the fact that Leishmania (Leishmania) amazonensis and 
Leishmania (Viannia) braziliensis have been detected in the human 
population10,11,12, studies on the isolation of species that cause CL in 
the State are scarce. 
From 2010 to 2013, 52 slides from cutaneous tissue imprints 
following punch biopsy, stained by the Giemsa method, with positive 
diagnosis of CL by direct examination were retrospectively scraped using 
a sterile scalpel for removal of all the material, which was inserted in 
a polypropylene tubes of 1.5 ml. Then, 600 μL of Cell Lysis Solution 
was added, and this solution was subjected to DNA extraction with 
a commercial kit (Promega Wizard® Genomic DNA Purification), 
following the manufacturer’s instructions. 
The PCR reaction was performed as described by VOLPINI et 
al.13 and DE ANDRADE et al.14. For amplification of the kinetoplast 
Fig. 1 – The State of Mato Grosso do Sul (MS) in Brazil
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DNA of Leishmania sp., the following primers were used: A: 5’-
(C/G)(C/G)(G/C)CC(C/A)CTA T(T/A)TTACACCAACCCC 3’ and B: 
5’-GGGGAGGGGCGTTCTGCGAA-3’. A fragment of 120 bp was 
obtained. 
Afterwards, 43 samples were considered positive, and subjected 
to RFLP analysis, where the PCR product was incubated with 10 U of 
the enzyme Hae III for 4 hours at 37 °C13. In all the reactions, DNA of 
L. braziliensis (MHOM/BR/75/M2903), L. infantum (MHOM/BR/74/
PP75), L. amazonensis (IFLA/BR/67/PH8), and negative controls were 
used. The DNA used as a positive control was obtained by washing 
parasites from a culture mass with PBS and a subsequent DNA extraction. 
A sample containing the reagents mixture with 5 μL of water, without 
DNA, was used as a negative control.
After the sample analysis, it was possible to characterize the species 
of Leishmania, in 40 patients, but in three cases the profile generated in 
RFLP was not conclusive. Thus, Leishmania (Leishmania) infantum was 
characterized in the lesions of seven patients with CL (17.5%) (Fig. 2). Of 
these patients, only one had coinfection with HIV and VL and presented 
skin lesions. The other patients did not exhibit immunodepression or the 
associated visceral disease during the diagnosis and therapy. 
Leishmania infantum has been identified as a causative agent of CL 
in humans from the Mediterranean. In the Southeast of Europe, this is 
the only species that has been detected in autochthonous cases5.
In France, a fairly comprehensive study examined all the cases of 
leishmaniasis in the country, from 2009 to 2012. At that time, of the 317 
autochthonous cases of leishmaniasis, 39 (12.3%) were cases of CL and 
all of them due to L. infantum2.
Cases of L. infantum as an etiological agent of CL have previously 
been described in the Americas15,16,17,18. In Brazil, this species was first 
reported in the cutaneous lesions of immunosupressed patients by 
OLIVEIRA NETO et al.19. However, in the State of Mato Grosso do Sul, 
this species has only been isolated in patients with VL12, 20.
The finding of L. infantum in lesions of patients with CL in Mato 
Grosso do Sul is expected, since there are several reports of the presence 
of this species causing this clinical manifestation in endemic areas for 
VL in the Old and New World, as already mentioned. The scarcity of 
molecular studies aimed at identifying the species involved in cases of 
CL in this area contributed to the fact that L. infantum have not been 
previously identified, so that CL cases for this etiology are probably 
underdiagnosed and certainly undernotified.
This is the first description of the participation of L. infantum as a 
causative agent of the disease in immunocompetent patients in Brazil.
The identification of Leishmania spp. in certain transmission foci, 
particularly in areas where different sympatric species occur is important 
since it will improve the epidemiological knowledge of this disease. In 
addition, it contributes to the adoption of control measures, improvement 
of prognosis, and selection of appropriate therapeutic protocols21,22,23. 
Besides the characterization of the species, the isoenzyme 
identification of circulating strains can provide important information 
about these dermotropics strains, as observed in different locations24,25. 
Further studies are required to isolate and characterize the different 
strains of Leishmania spp. that affect humans in Mato Grosso do Sul, 
and to gain a better understanding of their tropism for cutaneous areas.
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